Literature DB >> 29530389

Report of final results regarding brain and heart tumors in Sprague-Dawley rats exposed from prenatal life until natural death to mobile phone radiofrequency field representative of a 1.8 GHz GSM base station environmental emission.

L Falcioni1, L Bua1, E Tibaldi1, M Lauriola1, L De Angelis1, F Gnudi1, D Mandrioli1, M Manservigi1, F Manservisi1, I Manzoli1, I Menghetti1, R Montella1, S Panzacchi1, D Sgargi1, V Strollo1, A Vornoli1, F Belpoggi2.   

Abstract

BACKGROUND: In 2011, IARC classified radiofrequency radiation (RFR) as possible human carcinogen (Group 2B). According to IARC, animals studies, as well as epidemiological ones, showed limited evidence of carcinogenicity. In 2016, the NTP published the first results of its long-term bioassays on near field RFR, reporting increased incidence of malignant glial tumors of the brain and heart Schwannoma in rats exposed to GSM - and CDMA - modulated cell phone RFR. The tumors observed in the NTP study are of the type similar to the ones observed in some epidemiological studies of cell phone users.
OBJECTIVES: The Ramazzini Institute (RI) performed a life-span carcinogenic study on Sprague-Dawley rats to evaluate the carcinogenic effects of RFR in the situation of far field, reproducing the environmental exposure to RFR generated by 1.8 GHz GSM antenna of the radio base stations of mobile phone. This is the largest long-term study ever performed in rats on the health effects of RFR, including 2448 animals. In this article, we reported the final results regarding brain and heart tumors.
METHODS: Male and female Sprague-Dawley rats were exposed from prenatal life until natural death to a 1.8 GHz GSM far field of 0, 5, 25, 50 V/m with a whole-body exposure for 19 h/day.
RESULTS: A statistically significant increase in the incidence of heart Schwannomas was observed in treated male rats at the highest dose (50 V/m). Furthermore, an increase in the incidence of heart Schwann cells hyperplasia was observed in treated male and female rats at the highest dose (50 V/m), although this was not statistically significant. An increase in the incidence of malignant glial tumors was observed in treated female rats at the highest dose (50 V/m), although not statistically significant.
CONCLUSIONS: The RI findings on far field exposure to RFR are consistent with and reinforce the results of the NTP study on near field exposure, as both reported an increase in the incidence of tumors of the brain and heart in RFR-exposed Sprague-Dawley rats. These tumors are of the same histotype of those observed in some epidemiological studies on cell phone users. These experimental studies provide sufficient evidence to call for the re-evaluation of IARC conclusions regarding the carcinogenic potential of RFR in humans.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinogenicity; Life-span bioassay; Mobile phone; RF; Sprague-Dawley rats

Mesh:

Year:  2018        PMID: 29530389     DOI: 10.1016/j.envres.2018.01.037

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  26 in total

1.  Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut.

Authors:  Jiajun Luo; Hang Li; Nicole C Deziel; Huang Huang; Nan Zhao; Shuangge Ma; Xin Ni; Robert Udelsman; Yawei Zhang
Journal:  Environ Res       Date:  2019-12-06       Impact factor: 6.498

2.  Widespread diversity in the transcriptomes of functionally divergent limb tendons.

Authors:  Nathaniel P Disser; Gregory C Ghahramani; Jacob B Swanson; Susumu Wada; Max L Chao; Scott A Rodeo; David J Oliver; Christopher L Mendias
Journal:  J Physiol       Date:  2020-03-30       Impact factor: 5.182

3.  Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study.

Authors:  Joachim Schüz; Kirstin Pirie; Gillian K Reeves; Sarah Floud; Valerie Beral
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

4.  Personal radio use and cancer risks among 48,518 British police officers and staff from the Airwave Health Monitoring Study.

Authors:  He Gao; Maria Aresu; Anne-Claire Vergnaud; Dennis McRobie; Jeanette Spear; Andy Heard; Håvard Wahl Kongsgård; Deepa Singh; David C Muller; Paul Elliott
Journal:  Br J Cancer       Date:  2018-12-26       Impact factor: 7.640

Review 5.  Health Council of the Netherlands and evaluation of the fifth generation, 5G, for wireless communication and cancer risks.

Authors:  Lennart Hardell
Journal:  World J Clin Oncol       Date:  2021-06-24

6.  Development of health-based exposure limits for radiofrequency radiation from wireless devices using a benchmark dose approach.

Authors:  Uloma Igara Uche; Olga V Naidenko
Journal:  Environ Health       Date:  2021-07-17       Impact factor: 5.984

7.  Continuous Exposure to 1.7 GHz LTE Electromagnetic Fields Increases Intracellular Reactive Oxygen Species to Decrease Human Cell Proliferation and Induce Senescence.

Authors:  Jisu Choi; Kyeongrae Min; Sangbong Jeon; Nam Kim; Jeong-Ki Pack; Kiwon Song
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.379

8.  Comments on the US National Toxicology Program technical reports on toxicology and carcinogenesis study in rats exposed to whole-body radiofrequency radiation at 900 MHz and in mice exposed to whole-body radiofrequency radiation at 1,900 MHz.

Authors:  Lennart Hardell; Michael Carlberg
Journal:  Int J Oncol       Date:  2018-10-24       Impact factor: 5.650

Review 9.  The Contribution of In Vivo Mammalian Studies to the Knowledge of Adverse Effects of Radiofrequency Radiation on Human Health.

Authors:  Andrea Vornoli; Laura Falcioni; Daniele Mandrioli; Luciano Bua; Fiorella Belpoggi
Journal:  Int J Environ Res Public Health       Date:  2019-09-12       Impact factor: 3.390

10.  Assessment of Genotoxicity in Human Cells Exposed to Modulated Electromagnetic Fields of Wireless Communication Devices.

Authors:  David Schuermann; Christina Ziemann; Zeinab Barekati; Myles Capstick; Antje Oertel; Frauke Focke; Manuel Murbach; Niels Kuster; Clemens Dasenbrock; Primo Schär
Journal:  Genes (Basel)       Date:  2020-03-25       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.